BPC-157 and TB-500 peptide protocols for tendon healing, soft tissue injury, joint repair, and sports recovery — individually evaluated and administered by a licensed Nurse Practitioner in west El Paso.
Book Your BPC-157 ConsultationBPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from a protein found in human gastric juice. It is one of the most extensively researched peptides for tissue healing, with preclinical studies demonstrating significant acceleration of tendon, ligament, muscle, and nerve repair. Its primary mechanism is angiogenesis — the formation of new blood vessels in injured tissue — which directly addresses the reason tendons and ligaments heal so slowly: poor blood supply.
For patients with chronic soft tissue injuries that have plateaued in conventional physical therapy, BPC-157 provides a biological stimulus that rest and exercise alone cannot. It is used by athletes, post-surgical patients, and anyone with persistent tendon or joint pain that isn’t responding to standard care.
Accelerates healing of rotator cuff tears, patellar tendinopathy, Achilles tendon injuries, and biceps tendon damage by driving angiogenesis at the injury site.
Compresses muscle tear recovery time for hamstring, quad, and hip flexor strains — especially for athletes returning to high training volume.
BPC-157 for knee injuries supports cartilage regeneration and joint tissue repair, including soft tissue damage from ACL, meniscus, and patella injuries.
Promotes healing of ligament sprains that have been chronically slow to resolve due to poor vascular supply in connective tissue.
Used by CrossFit athletes and strength athletes to return to full training load faster after soft tissue injuries that haven’t responded to rest.
Oral BPC-157 is effective for IBS, leaky gut, inflammatory bowel disease, and GI repair — the one application where oral administration is preferred over injection.
The following dosage ranges reflect general clinical practice. All BPC-157 protocols at Solas Health & Wellness are individually designed by Celeste Cisneros, NP based on your injury severity, body weight, and recovery goals.
| Parameter | BPC-157 | TB-500 (Combo) |
|---|---|---|
| Daily Dose | 250–500 mcg/day | 2–5 mg/week |
| Route | Subcutaneous (near injury site) | Subcutaneous (any site) |
| Frequency | Once or twice daily | 1–2× per week |
| Loading Phase | 4–8 weeks | 4–6 weeks |
| Maintenance | Taper or cycle off | 1–2 mg/week, 2–4 weeks |
| Gut Application | Oral caps, 500–1000 mcg | N/A |
“Never source BPC-157 without clinical supervision. Proper dosing, sterility, reconstitution, and protocol design require a licensed provider. At Solas Health & Wellness, every protocol begins with a full health evaluation by Celeste Cisneros, NP.”
The most effective peptide protocol for soft tissue injuries combines BPC-157 with TB-500 (Thymosin Beta-4) — known as the Wolverine Stack. BPC-157 drives local tissue repair through angiogenesis at the injury site; TB-500 works systemically to regulate actin, reduce whole-body inflammation, and promote cell migration throughout the body. Together they address both the local injury and the systemic inflammatory environment simultaneously.
Celeste Cisneros, NP offers the complete Wolverine Stack at Solas Health & Wellness — including a pre-mixed BPC-157 + TB-500 blend for patient convenience and precision dosing. For patients who want to maximize the protocol with physical therapy, the BPC-157 + PT combination is even more powerful. Learn more at Solas PT’s Wolverine Stack guide.
Peptides create the biological conditions for healing. They do not rebuild strength, restore movement patterns, or retrain the neuromuscular system. That work requires a skilled physical therapist who understands both tissue biology and functional biomechanics. For patients in El Paso, Celeste coordinates directly with Dr. Andrew Cisneros, PT, DPT, MS at Solas PT to deliver an integrated BPC-157 + PT recovery plan.
Joint mobilization and soft tissue work to restore range of motion and tissue quality in the early healing phase — working with what BPC-157 is building.
Combined with BPC-157, dry needling creates a synergistic local effect — trigger point release + angiogenic stimulus — particularly powerful for chronic tendon injuries.
Progressive tendon loading and eccentric strengthening rebuild the capacity the injury eroded, turning BPC-157’s healing window into lasting functional improvement.
Restoring the movement patterns and motor control that compensatory movement changes during injury. Critical for preventing the same injury from recurring.
Dr. Cisneros specializes in manual therapy, dry needling, and sports performance physical therapy — one-on-one, every session. He coordinates directly with Celeste to build integrated peptide + PT recovery plans for patients using BPC-157 and the Wolverine Stack in El Paso.
Book Physical Therapy at Solas PT →Tendon, ligament & soft tissue healing
Systemic tissue repair & inflammation
Growth hormone support & recovery
Myers Cocktail, hydration & nutrient drip
Antioxidant & detoxification IV push
Advanced regenerative cellular therapy
Hormone replacement & optimization
Weight management & metabolic health
Celeste is a licensed Nurse Practitioner specializing in regenerative medicine and peptide therapy — BPC-157, TB-500, Wolverine Stack, IV therapy, hormone optimization, and more. She evaluates each patient individually and designs protocols based on your specific injury, goals, and health history. Her clinical partnership with Solas PT means your peptide and PT protocols are coordinated from day one.
Book a Consultation with Celeste →BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from a protein found in human gastric juice. It is researched for its ability to accelerate healing of tendons, ligaments, muscles, and joints by promoting angiogenesis — the formation of new blood vessels in poorly vascularized injured tissue. This makes it especially effective for tendon and ligament injuries that heal slowly due to poor blood supply.
BPC-157 is not FDA-approved for therapeutic human use and is classified as an unapproved investigational compound in the US. It cannot legally be sold as a drug or dietary supplement. However, BPC-157 may be prescribed and administered by a licensed healthcare provider in a supervised clinical setting. At Solas Health & Wellness, Celeste Cisneros, NP administers BPC-157 within a fully supervised medical framework — with a complete patient evaluation and health history review before any protocol begins.
BPC-157 injections (subcutaneous) are more effective for soft tissue injuries, tendon repair, and muscle healing because injection delivers significantly higher bioavailability near the injured tissue. Oral BPC-157 is the preferred route only for gut-related conditions — IBS, leaky gut, inflammatory bowel disease — where the peptide acts on GI tissue during digestion. For athletes or patients with tendon, ligament, or joint injuries, subcutaneous injection is the standard and more effective protocol.
The standard clinical range is 250–500 mcg per day administered subcutaneously near the injury site. Some protocols use twice-daily dosing for more severe injuries. BPC-157 dosage should always be individualized by a licensed clinician based on your injury severity, body weight, and recovery goals — never based solely on online guides. Celeste Cisneros, NP designs personalized BPC-157 dosage protocols for each patient at Solas Health & Wellness.
Most protocols run 4–8 weeks for acute soft tissue injuries, with some clinicians extending to 12 weeks for chronic or severe conditions. Longer cycles are generally run with periodic breaks — an 8-weeks-on, 4-weeks-off approach is common. Because BPC-157 is not FDA-approved, cycle length and structure must always be determined by a licensed clinician who monitors your individual response throughout the protocol.
For knee injuries, BPC-157 is ideally injected subcutaneously near the site of pain — typically the medial or lateral aspect of the knee, or intra-articularly (into the joint space) when clinically indicated. Because BPC-157’s primary mechanism is local angiogenesis, injection proximity to the injured tissue matters significantly for efficacy. Celeste Cisneros, NP determines the optimal injection site based on your specific knee injury — whether patellar tendinopathy, ACL, meniscus, or cartilage damage.
BPC-157 promotes tendon healing by stimulating angiogenesis — the formation of new blood vessels in poorly vascularized connective tissue. Tendons heal slowly because they receive very little blood supply; BPC-157 directly addresses this biological bottleneck by creating a vascular environment that delivers nutrients, growth factors, and repair signals to the injury site. It has been studied for rotator cuff tears, patellar tendinopathy, Achilles tendon injuries, and biceps tendon damage.
BPC-157 has a generally favorable safety profile based on available preclinical research and clinical reports, with rare and mild side effects including temporary injection site irritation, nausea, or dizziness. Because BPC-157 is not FDA-approved for human use, clinical supervision is essential — not optional. Celeste Cisneros, NP conducts a thorough intake evaluation and health history review before recommending any peptide protocol to ensure it is appropriate for your individual situation.
The Wolverine Stack is a peptide protocol combining BPC-157 and TB-500 (Thymosin Beta-4). BPC-157 drives local tissue repair at the injury site through angiogenesis; TB-500 works systemically to reduce whole-body inflammation, regulate actin, and promote cell migration throughout the body. Together they produce faster and more complete soft tissue healing than either peptide achieves alone. Celeste Cisneros, NP offers the complete Wolverine Stack, including a pre-mixed BPC-157 + TB-500 blend, at Solas Health & Wellness in El Paso.
Yes — and this is the most effective combination. BPC-157 creates the cellular and vascular conditions for healing; physical therapy ensures the healing tissue is progressively loaded, mobilized, and strengthened into full functional capacity. Celeste Cisneros, NP coordinates directly with Dr. Andrew Cisneros, DPT at Solas PT to deliver integrated peptide + physical therapy recovery plans for patients in El Paso.
BPC-157 protocol pricing varies based on dosage, cycle length, and clinical services included. At Solas Health & Wellness, pricing is transparent and provided upfront during your initial consultation. The cost of a clinically supervised protocol with Celeste Cisneros, NP includes a full health evaluation, individualized dosing plan, and ongoing monitoring — not just the peptide compound. Contact solasclinic.com for current pricing information.
Most patients report noticeable improvement within 2–4 weeks of starting BPC-157. Acute soft tissue injuries typically show the earliest response; chronic tendon conditions that have been present for months may take 4–6 weeks before significant change is felt. Pain reduction often precedes structural healing — tissue rebuilding continues even after symptoms improve. Running BPC-157 concurrently with physical therapy at Solas PT accelerates functional improvement because the peptide’s healing window is being actively loaded through progressive exercise.
The standard BPC-157 cycle length is 4–8 weeks for acute injuries. Chronic or more severe conditions may warrant a 10–12 week cycle. A common protocol structure is 8 weeks on, followed by a 4-week break before reassessing. There is no established evidence of tolerance buildup with BPC-157, but periodic cycling is standard practice given the absence of long-term human data. Celeste Cisneros, NP determines your cycle length based on your injury severity, response to treatment, and recovery goals.
BPC-157 nasal spray is an intranasal delivery method where the peptide is absorbed through the nasal mucosa. It is sometimes used for neurological applications — brain injury recovery, cognitive support, and anxiety — because intranasal delivery provides a more direct route to the central nervous system. However, for soft tissue injuries like tendon tears, muscle strains, and joint damage, subcutaneous injection near the injury site remains significantly more effective than nasal spray because BPC-157’s primary mechanism (local angiogenesis) depends on proximity to the injured tissue. Celeste Cisneros, NP will recommend the appropriate delivery route based on your specific condition.
Based on available preclinical research, BPC-157 does not appear to cause cancer and has not been shown to promote tumor growth in animal studies. Some research actually suggests it may have anti-inflammatory and cytoprotective properties. However, because BPC-157 promotes angiogenesis (blood vessel formation), it is generally not recommended for individuals with active cancer or a history of certain hormone-sensitive malignancies without oncologist guidance. This is one of many reasons clinical supervision by a licensed provider like Celeste Cisneros, NP is essential — she reviews your full health history before prescribing any protocol.
BPC-157 is not a steroid — it is a synthetic peptide derived from a gastric protein with a completely different mechanism of action from anabolic steroids. It does not affect testosterone, estrogen, or other hormones. BPC-157 is not currently included in standard WADA anti-doping panels or typical workplace/military drug screens, which test for very different compound classes. However, it is on the WADA monitoring list, and professional athletes should confirm current testing protocols with their governing body before use. Celeste Cisneros, NP can discuss this in your consultation.
BPC-157 is one of the few peptides with strong evidence for gastrointestinal healing. In this application, oral BPC-157 capsules are preferred over injection because the peptide acts directly on GI tissue during digestion. BPC-157 reduces gut inflammation, promotes healing of the intestinal lining, and has been studied for IBS, Crohn’s disease, GERD, ulcerative colitis, and leaky gut syndrome. Dosing for gut applications typically runs 500–1000 mcg orally per day. Celeste Cisneros, NP can evaluate whether BPC-157 is appropriate for your gastrointestinal condition.
BPC-157 promotes angiogenesis and has anti-inflammatory properties that may support hair follicle health. Some users and early research suggest it may help with hair loss conditions that have an inflammatory or vascular component — including alopecia areata and traction alopecia. TB-500 (Thymosin Beta-4) is more commonly cited for hair growth promotion due to its role in activating hair follicle stem cells. The recommended approach for hair restoration is often a combination of BPC-157 + TB-500 (the Wolverine Stack) with individualized dosing. Celeste Cisneros, NP can evaluate your specific hair loss presentation during a consultation.
BPC-157 benefits for women are similar to those for men: accelerated tendon healing, soft tissue repair, gut health support, joint recovery, and reduced inflammation. Women generally use the same dosage range as men — 250–500 mcg per day subcutaneously — though some clinicians recommend starting at the lower end. There are no established interactions with hormonal contraceptives. Women who are pregnant or breastfeeding should not use BPC-157, as no human safety data exists for these populations. Celeste Cisneros, NP provides gender-specific evaluation and dosing guidance during each consultation.
BPC-157 may support recovery from herniated and bulging discs through its angiogenic and anti-inflammatory effects on surrounding connective tissue, ligaments, and muscles. While it cannot mechanically reposition a herniated disc, it may reduce the inflammatory cascade that causes nerve compression pain and promote healing of the soft tissue structures that support the spine. For herniated disc patients, BPC-157 combined with physical therapy — including manual therapy and targeted spine stabilization — at Solas PT represents the most comprehensive non-surgical approach available.
A commonly used calculation for BPC-157 dosage is 2–4 mcg per kilogram of body weight per day. For a 75 kg (165 lb) person, this works out to 150–300 mcg/day at the lower end, or up to 500 mcg/day at higher therapeutic doses. This per-weight calculation is used as a starting framework, but injury severity, treatment goals, and individual response are equally important factors. Celeste Cisneros, NP at Solas Health & Wellness calculates an individualized dosage for each patient rather than applying a generic formula.
Celeste Cisneros, NP will evaluate your injury, design your individualized BPC-157 or Wolverine Stack protocol, and coordinate with Solas PT if physical therapy is part of your recovery plan.
Book Your BPC-157 Consultation Add Physical Therapy at Solas PT →